Abbvie Inc Stock Chance of Future Stock Price Finishing Over 187.57
| ABBV Stock | USD 170.35 0.74 0.43% |
AbbVie |
AbbVie Target Price Odds to finish over 187.57
The tendency of AbbVie Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 187.57 or more in 90 days |
| 170.35 | 90 days | 187.57 | about 80.5 |
Based on a normal probability distribution, the odds of AbbVie to move over $ 187.57 or more in 90 days from now is about 80.5 (This AbbVie Inc probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 90 days) . Probability of AbbVie Inc price to stay between its current price of $ 170.35 and $ 187.57 at the end of the 90-day period is about 19.48 .
Given the investment horizon of 90 days AbbVie has a beta of 0.0488. This suggests as returns on the market go up, AbbVie average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AbbVie Inc will be expected to be much smaller as well. Additionally AbbVie Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. AbbVie Price Density |
| Price |
Predictive Modules for AbbVie
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AbbVie Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AbbVie Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AbbVie is not an exception. The market had few large corrections towards the AbbVie's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AbbVie Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AbbVie within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 5.91 | |
Ir | Information ratio | -0.15 |
AbbVie Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AbbVie for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AbbVie Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AbbVie Inc generated a negative expected return over the last 90 days | |
| AbbVie Inc currently holds 59.38 B in liabilities with Debt to Equity (D/E) ratio of 4.37, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about AbbVie's use of debt, we should always consider it together with its cash and equity. | |
| About 73.0% of AbbVie shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: AbbVies Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio |
AbbVie Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AbbVie Stock often depends not only on the future outlook of the current and potential AbbVie's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AbbVie's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.8 B | |
| Cash And Short Term Investments | 12.8 B |
AbbVie Technical Analysis
AbbVie's future price can be derived by breaking down and analyzing its technical indicators over time. AbbVie Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AbbVie Inc. In general, you should focus on analyzing AbbVie Stock price patterns and their correlations with different microeconomic environments and drivers.
AbbVie Predictive Forecast Models
AbbVie's time-series forecasting models is one of many AbbVie's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AbbVie's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about AbbVie Inc
Checking the ongoing alerts about AbbVie for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AbbVie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| AbbVie Inc generated a negative expected return over the last 90 days | |
| AbbVie Inc currently holds 59.38 B in liabilities with Debt to Equity (D/E) ratio of 4.37, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about AbbVie's use of debt, we should always consider it together with its cash and equity. | |
| About 73.0% of AbbVie shares are held by institutions such as insurance companies | |
| Latest headline from benzinga.com: AbbVies Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio |
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.